Matches in Nanopublications for { ?s ?p "[Losses of CDKN2A (9p21) and MLH1 (3p22) and gains of CCND1, EMS1 (both at 11q13), RECQL4 and PTP4A3 (both at 8q24) were the most frequent aberrations in both larynx and pharynx carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP259448.RAZc9C-qkPTOUlGdt3sD4va6aUF-2P_a50fnrX560-wsc130_assertion description "[Losses of CDKN2A (9p21) and MLH1 (3p22) and gains of CCND1, EMS1 (both at 11q13), RECQL4 and PTP4A3 (both at 8q24) were the most frequent aberrations in both larynx and pharynx carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP259448.RAZc9C-qkPTOUlGdt3sD4va6aUF-2P_a50fnrX560-wsc130_provenance.
- NP602675.RAiSBWKbZRyep-wt04-3znsp9yLqcymhOfSUB2VzegRRc130_assertion description "[Losses of CDKN2A (9p21) and MLH1 (3p22) and gains of CCND1, EMS1 (both at 11q13), RECQL4 and PTP4A3 (both at 8q24) were the most frequent aberrations in both larynx and pharynx carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP602675.RAiSBWKbZRyep-wt04-3znsp9yLqcymhOfSUB2VzegRRc130_provenance.
- NP663199.RA_iSvAJf_5JmIqM9v6nc01_wQyD9dEFDtMewxoh3L1Rw130_assertion description "[Losses of CDKN2A (9p21) and MLH1 (3p22) and gains of CCND1, EMS1 (both at 11q13), RECQL4 and PTP4A3 (both at 8q24) were the most frequent aberrations in both larynx and pharynx carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP663199.RA_iSvAJf_5JmIqM9v6nc01_wQyD9dEFDtMewxoh3L1Rw130_provenance.
- NP374357.RAQQRI5Nc6qw35DCbZRumGRegy61__ybnlUPOZ9T9ld-A130_assertion description "[Losses of CDKN2A (9p21) and MLH1 (3p22) and gains of CCND1, EMS1 (both at 11q13), RECQL4 and PTP4A3 (both at 8q24) were the most frequent aberrations in both larynx and pharynx carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP374357.RAQQRI5Nc6qw35DCbZRumGRegy61__ybnlUPOZ9T9ld-A130_provenance.
- NP860874.RAvoT5eWr3XgBo1K2foaYjnwY4bqPKgH70shVbtAk3xNw130_assertion description "[Losses of CDKN2A (9p21) and MLH1 (3p22) and gains of CCND1, EMS1 (both at 11q13), RECQL4 and PTP4A3 (both at 8q24) were the most frequent aberrations in both larynx and pharynx carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP860874.RAvoT5eWr3XgBo1K2foaYjnwY4bqPKgH70shVbtAk3xNw130_provenance.
- NP822410.RA34auYgpRnuHZE8EQvDwlGzvtzTpu0sJ5OJS50ZY5i6s130_assertion description "[Losses of CDKN2A (9p21) and MLH1 (3p22) and gains of CCND1, EMS1 (both at 11q13), RECQL4 and PTP4A3 (both at 8q24) were the most frequent aberrations in both larynx and pharynx carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP822410.RA34auYgpRnuHZE8EQvDwlGzvtzTpu0sJ5OJS50ZY5i6s130_provenance.